AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CICLOPIROXOLAMINE
25 registrations across 5 African markets— 16 active
Markets with CICLOPIROXOLAMINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MYCOSTER 1% SOLUTION SOLUTION LOCALE FLACON DE 30ML | 🇨🇮Côte d'Ivoire | PIERRE FABRE DERMATOLOGIE | expired | May 2024 |
| MYCOSTER 1% CREME TUBE DE 30G | 🇨🇮Côte d'Ivoire | PIERRE FABRE DERMATOLOGIE | expired | May 2022 |
| MYCOREX VERNIS Solution externe / 8% | 🇹🇳Tunisia | OPALIA PHARMA | expired | Apr 2017 |
| MYCOSTER Poudre a usage externe / 1% | 🇹🇳Tunisia | PIERRE FABRE DERMATOLOGIE | expired | Nov 2004 |
| MYCOREX Creme dermique / 1 % | 🇹🇳Tunisia | OPALIA PHARMA | expired | Dec 1999 |
| MYCOREX Lotion / 1% | 🇹🇳Tunisia | OPALIA PHARMA | expired | Aug 1999 |
| MYCOSTER VERNIS Solution externe / 8% | 🇹🇳Tunisia | PIERRE FABRE DERMATOLOGIE | expired | Jun 1996 |
| MYCOSTER Creme dermique / 1% | 🇹🇳Tunisia | SIMED | expired | Feb 1995 |
| MYCOSTER Spray solution / 1% | 🇹🇳Tunisia | SIMED | expired | Feb 1995 |
| SEBIPROX SOLUTION POUR APPLICATION LOCALE | 🇲🇦Morocco | — | active | — |
| MYCOSTER 1% POUDRE POUDRE POUDRE POUR APPLICATION CUTANEE FLACON DE 30G | 🇨🇮Côte d'Ivoire | PIERRE FABRE DERMATOLOGIE | active | — |
| BRUMIXOL ovule / 100 mg | 🇸🇳Senegal | OPALIA | active | — |
| MYCOSTER solution filogène / 8 % | 🇸🇳Senegal | PIERRE FABRE | active | — |
| BRUMIXOL crème dermique / 1 g | 🇸🇳Senegal | OPALIA | active | — |
| MYCOSTER 1% CR BTE (1 TBEX30G) PIERRE FABRE DERMATOLOGIE crème 1%, tube de 30g | 🇲🇬Madagascar | PIERRE FABRE DERMATOLOGIE | active | — |
| MYCOSTER 1% SPAC BTE (1 FLX30ML) PIERRE FABRE DERMATOLOGIE solution pour application | 🇲🇬Madagascar | PIERRE FABRE MEDICAMENT | active | — |
| BRUMIXOL lotion / 1 g | 🇸🇳Senegal | OPALIA | active | — |
| MYCOSTER CREME | 🇲🇦Morocco | — | active | — |
| MYCOSTER SOLUTION POUR APPLICATION LOCALE | 🇲🇦Morocco | — | active | — |
| MYCOSTER 1% CR BTE (1 TBEX30G) PIERRE FABRE DERMATOLOGIE crème 1%, tube de 30g | 🇲🇬Madagascar | PIERRE FABRE DERMATOLOGIE | active | — |
| MYCOSTER 1% SPAC BTE (1 FLX30ML) PIERRE FABRE DERMATOLOGIE solution pour application | 🇲🇬Madagascar | PIERRE FABRE MEDICAMENT | active | — |
| MYCOSTER poudre / 1 % | 🇸🇳Senegal | PIERRE FABRE | active | — |
| MYCOSTER crème dermique / 1 % | 🇸🇳Senegal | PIERRE FABRE | active | — |
| MYCOSTER SOLUTION POUR APPLICATION LOCALE | 🇲🇦Morocco | — | active | — |
| BRUMIXOL CREME | 🇲🇦Morocco | — | active | — |
CICLOPIROXOLAMINE in Africa — Regulatory Overview
CICLOPIROXOLAMINE is registered across 5 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Senegal, Morocco, Madagascar and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 16 (64%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.